Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 eBioMedicine Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications